ClinicalTrials.gov
ClinicalTrials.gov Menu

Temozolomide in Treating Young Patients With Refractory or Recurrent Leukemia

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00083070
Recruitment Status : Completed
First Posted : May 17, 2004
Last Update Posted : February 20, 2014
Sponsor:
Collaborator:
National Cancer Institute (NCI)
Information provided by (Responsible Party):
Children's Oncology Group

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : September 2004
  Actual Study Completion Date : June 2008
Publications of Results: